Journey Medical Corporation (NASDAQ:DERM) Q1 2026 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q1 2026 Earnings Call Transcript May 13, 2026Journey Medical Corporation misses on earnings expectations.
Journey Medical Corp (DERM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Tang Capital Management Kevin C. Tang | 1,610,000 | $7,550,900 | -14% | 0.38% |
| 2. | Opaleye Management James A. Silverman | 960,000 | $4,502,400 | -2% | 0.59% |
| 3. | Pale Fire Capital Dusan Senkypl, David Holy, And Jan Barta | 481,987 | $2,260,519 | +9% | 0.2% |
| 4. | Millennium Management Israel Englander | 383,067 | $1,796,584 | -17% | 0% |
| 5. | Ikarian Capital Neil Shahrestani | 251,436 | $1,179,235 | 0.1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.04 | 10,000 | $30,400.00 | 144,245 | 2024-03-25 | Filing | |
| $3.48 | 10,000 | $34,790.00 | 2,163,430 | 2024-03-22 | Filing | |
| $3.47 | 30,000 | $104,100.00 | 134,717 | 2024-03-22 | Filing | |
| $3.40 | 20,000 | $68,000.00 | 134,245 | 2024-03-22 | Filing | |
| $2.98 | 33,000 | $98,340.00 | 104,717 | 2023-10-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.84 | 4,834 | $33,064.56 | 2,348,313 | 2025-05-02 | Filing | |
| $6.84 | 2,409 | $16,477.56 | 203,557 | 2025-05-02 | Filing | |
| $6.84 | 2,857 | $19,541.88 | 504,817 | 2025-05-02 | Filing | |
| $5.01 | 49,271 | $246,847.71 | 2,003,147 | 2025-03-11 | Filing | |
| $5.01 | 14,905 | $74,674.05 | 2,052,418 | 2025-03-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,133,370 | $10,005,505 | 0.07% | |
| 2. | 1,082,080 | $5,074,955 | 0% | |
| 3. | 972,862 | $4,562,724 | 0% | |
| 4. | 500,188 | $2,345,882 | 0.07% | |
| 5. | 463,202 | $2,172,918 | 0% |
News See All
Journey Medical Corporation (NASDAQ:DERM) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's Full Year 2025 Financial Results and Corporate Update Conference Call.
Journey Medical (DERM) Publishes Positive Emrosi Phase 1 Microbiome Data
Journey Medical Corp (NASDAQ:DERM) is one of the best performing micro cap stocks in 2025.
9 Best Performing Micro Cap Stocks in 2025
A Bloomberg report published on January 2, 2026, argues that 2025 was an everything rally.
What Makes Journey Medical Corporation (DERM) a Good Investment?
Summers Value Partners, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript November 12, 2025Journey Medical Corporation misses on earnings expectations.
Summers Value Partners’ Update on Journey Medical (DERM)
Summers Value Partners, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Journey Medical Corporation (NASDAQ:DERM) Q2 2025 Earnings Call Transcript
Journey Medical Corporation (NASDAQ:DERM) Q2 2025 Earnings Call Transcript August 12, 2025Journey Medical Corporation misses on earnings expectations.
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Journey Medical's First Quarter 2025 Financial Results and Corporate Update Conference Call.
Why These 15 Healthcare Stocks Are Surging in 2025
After lagging behind the broader market in 2024, many healthcare stocks are making a comeback this year.
Hedge Fund Resource Center